186 related articles for article (PubMed ID: 33911617)
1. Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata.
Zhang L; Xu X; Chen S; Kang Y; Wang X; Zhang C; Xiang L
Ann Dermatol; 2019 Aug; 31(4):393-402. PubMed ID: 33911617
[TBL] [Abstract][Full Text] [Related]
2. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis.
Ferrari SM; Fallahi P; Santaguida G; Virili C; Ruffilli I; Ragusa F; Centanni M; Antonelli A
Autoimmun Rev; 2017 Sep; 16(9):946-950. PubMed ID: 28698095
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of interleukin-17 in patients with alopecia areata and non-segmental vitiligo.
Tomaszewska KA; Kozłowska M; Kaszuba A; Lesiak A; Narbutt J; Zalewska-Janowska AM
Postepy Dermatol Alergol; 2022 Feb; 39(1):195-199. PubMed ID: 35369638
[TBL] [Abstract][Full Text] [Related]
4. Increased Serum Levels of IFN-
Tomaszewska K; Kozłowska M; Kaszuba A; Lesiak A; Narbutt J; Zalewska-Janowska A
Oxid Med Cell Longev; 2020; 2020():5693572. PubMed ID: 32832001
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata.
Zainodini N; Hassanshahi G; Arababadi MK; Khorramdelazad H; Mirzaei A
Iran J Immunol; 2013 Mar; 10(1):40-6. PubMed ID: 23502337
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms.
Gey A; Diallo A; Seneschal J; Léauté-Labrèze C; Boralevi F; Jouary T; Taieb A; Ezzedine K
Br J Dermatol; 2013 Apr; 168(4):756-61. PubMed ID: 23253044
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in Vitiligo Pathogenesis: CXCL10 and 12.
Gharib K; Gadallah H; Elsayed A
J Clin Aesthet Dermatol; 2021 Sep; 14(9):27-32. PubMed ID: 34980968
[TBL] [Abstract][Full Text] [Related]
8. Assessment of CXCL10 Before and After Narrow Band UVB Phototherapy in Non-Segmental Vitiligo Patients.
Hussein SM; Sorour MAEH; Samir M; Abd El Azim SA; Hossain A
Indian J Dermatol; 2022; 67(4):319-323. PubMed ID: 36578753
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
12. The Frequency of Autoimmune Thyroid Disease in Alopecia Areata and Vitiligo Patients.
Saylam Kurtipek G; Cihan FG; Erayman Demirbaş Ş; Ataseven A
Biomed Res Int; 2015; 2015():435947. PubMed ID: 26355833
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Serum Oxidative Stress Markers to Assess Disease Activity and Severity in Patients With Non-Segmental Vitiligo.
Li S; Dai W; Wang S; Kang P; Ye Z; Han P; Zeng K; Li C
Front Cell Dev Biol; 2021; 9():739413. PubMed ID: 34977005
[TBL] [Abstract][Full Text] [Related]
14. New insights into segmental vitiligo: A clinical and immunological comparison with nonsegmental vitiligo.
Xu X; Jiang M; Zhang C; Qiao Z; Liu W; Le Y; Wu J; Ma W; Xiang LF
Pigment Cell Melanoma Res; 2022 Mar; 35(2):220-228. PubMed ID: 34780118
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes.
Speeckaert R; Belpaire A; Speeckaert MM; van Geel N
Front Immunol; 2023; 14():1112811. PubMed ID: 36911664
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Transplantation of Cultured Autologous Melanocytes on CXCL9, CXCL10 and CXCL11 Expressions in Vitiligo.
Xu C; Lei Z; Wang L; Wang H; Hu W; Hairuola H; Kang X
Indian J Dermatol; 2023; 68(4):486. PubMed ID: 37822411
[TBL] [Abstract][Full Text] [Related]
17. Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome.
El-Domyati M; El-Din WH; Rezk AF; Chervoneva I; Lee JB; Farber M; Uitto J; Igoucheva O; Alexeev V
Arch Dermatol Res; 2022 Apr; 314(3):275-284. PubMed ID: 33866437
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata.
Chanprapaph K; Mahasaksiri T; Kositkuljorn C; Leerunyakul K; Suchonwanit P
J Inflamm Res; 2021; 14():4881-4891. PubMed ID: 34588794
[TBL] [Abstract][Full Text] [Related]
19. Organ specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata.
Noso S; Park C; Babaya N; Hiromine Y; Harada T; Ito H; Taketomo Y; Kanto K; Oiso N; Kawada A; Suzuki T; Kawabata Y; Ikegami H
J Clin Endocrinol Metab; 2015 May; 100(5):1976-83. PubMed ID: 25734250
[TBL] [Abstract][Full Text] [Related]
20. Differentially expressed microRNAs in peripheral blood mononuclear cells of non-segmental vitiligo and their clinical significance.
Zhang Z; Yang X; Liu O; Cao X; Tong J; Xie T; Zhang J; Peng Y
J Clin Lab Anal; 2021 Feb; 35(2):e23648. PubMed ID: 33169883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
